Editorial: Cellular metabolism, the immune system, and oncogenesis: opportunities for drug discovery and development
Nearly a century after Otto Warburg first described a unique phenomenon whereby tumour cells prefer the inefficient glycolytic pathway for energy generation (Warburg, 1956), the phenomenon has continued to aid researchers in exploring the tumour ecosystem, including tumour initiation, progression and targeting. Further...